Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,015 across all filing types
Latest filing 2018-10-24 Director's Dealing
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2018-10-24 English
SCHEDULE 13D/A, AMENDMENT #1
Major Shareholding Notification
2018-10-19 English
FORM 4
Director's Dealing
2018-10-19 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated October 1, 2018. It announces a change in the company's independent registered public accounting firm from EKS&H LLLP to Plante & Moran PLLC. The content focuses on the resignation of the previous auditor, the engagement of the new auditor, and related disclosures about audit opinions and disagreements. There are no financial statements or detailed audit reports included, only a notification of the change and related information. This type of filing is a regulatory announcement about auditor change and does not contain the audit report itself or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-10-04 English
FORM DEFR14A
Remuneration Information Classification · 100% confidence The document is titled 'Supplement to Proxy Statement' and is identified as an Amendment No. 1 to a definitive proxy statement on Schedule 14A filed with the SEC. It corrects errors in the Summary Compensation table for named executive officers, which is part of executive compensation disclosures typically included in proxy statements. The document references the original Proxy Statement and does not present financial statements or results but rather amends compensation data. It also includes a notice about the availability of proxy materials for the upcoming Annual Meeting. The form DEFR14A and Schedule 14A are standard filings for proxy statements related to shareholder meetings and executive compensation disclosures. Therefore, this document is best classified as Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2018-09-26 English
PRIMARY DOCUMENT
Director's Dealing
2018-09-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.